6 January 2009 E-MAIL SEARCH
Home Page
Newsroom
From the Top
Business Buzz
Marketing Mix
Financial Focus
Management Matters
PR Points
Web Wisdom
Industry Reports
Business Glossary
Resources
U.S. Gov. Resources
Print this page Bookmark this page
  
  Trendletter > December 2008
 

December 2008 Volume 10 | No. 12

Trendletter Icons
Look for these colorful icons to help you readily identify Trendletter content.
From the Top Client News Team News Original article Incubator

Program/
conference announcement

Program/
conference report
Hebrew


From the Top: In Defense of Finders
It’s the truth. Raising money is hard work. It’s one more full-time job for a CEO who already has several full-time jobs. So, are you making it harder on yourself that it need be? Let’s consider one of the classes of professionals, semi-professionals (and unprofessionals) who offer to help “do” your raise -- the “finder.”

The “finder.” This sounds like a guy who stumbles upon opportunities, making money from his luck and occasional knowledge of phone numbers. Sometimes, that’s the case. Some finders, though, are true professionals. Finders -- to my definition -- do not ask for retainers. They work on a commission and are paid as they succeed. Some finders will ask for both a cash commission and warrants. While the term “finder” is often used derisively, I believe that as a group they are an important part of a fund-raising plan.

We are privileged to work with finders around the world who are honest in their dealings and successful for their clients. Professional finders have relationships with investors they know well; they are always prospecting for new investors to add to their portfolios.

Typically, finders spend little time with your business plan and other support materials. If they don’t find your presentation or business plan acceptable, they will tell you to fix it. Their focus is on getting you to investors -- not on strategies and plans.

Whatever you call them -- finders, machers, investment bankers -- these “connectors” can make the difference between success and death for a company. At all times -- and especially during these times -- I encourage you to speak to many and engage -- non-exclusively -- those whom you feel comfortable with and will work to help you and your company.

And because you should engage them non-exclusively and because they cannot commit to any investment -- they can only bring you an investor for your consideration. I beg you: Don’t get overly focused on the fees that they request from you. Get focused on the investors that they bring you and the total cost of the deal -- their commission and warrants are part of the total cost of the deal. I see companies spending more time negotiating with finders than they spend talking to investors. That’s the wrong balance.

You can only understand what a deal costs when see the valuation offered and the full set of terms presented. The finder who asks you for 7% cash plus 7% options is a bargain when he brings you the money that you need at the valuation that you want. Focus on the total cost of the deal.

Remember, you can always (and you must) say “no” to a bad deal -- and a bad investor. Say "yes" to your finder and deal with the investor when he is at hand. Stop thinking that the finder is getting lots of money “just for making a phone call,” and start thinking that you will be thrilled to write him a big check.


D. Todd Dollinger, CEO
The Trendlines Group

See the From the Top archives.

What Is Trendlines International?
Israel's premier business development and marketing consulting firm. We provide a range of business development, seed investing, and marketing communications services.

Building on our experience, we research and analyze markets and opportunities to understand your business. From that understanding, we develop a plan and help you implement it.

We think our 6-factor formula sums it up well: Experience + Research + Analysis
= Understanding --> Planning --> Implementation.

Register Now for the MarketReach America LIfe Sciences & Medical Devices 2009 Seminar

Reaching Customers and Getting Paid in the U.S. Healthcare Market
13 January 2009, 09:00-15:30
International Convention Center Haifa (Mercaz Congressim Benleumi Haifa)

Program Highlights

  • Introduction to healthcare reimbursement
  • What's "hot" in coding, coverage & payment in the U.S. healthcare market
  • Perspective from a skeptical payor: Coding, coverage and payment from the Inside
  • From producer to patient: getting the products to market

Featured Speakers

  • Lynn Shapiro Snyder, director, Health Care Practice, Epstein, Becker & Green
  • Marcia Nusgart, president, Nusgart Consulting (medical device industry lobbying organization)
  • Dr. Jan Berger, former senior VP and chief clinical officer for CVS Caremark
  • Dan Moskowitz, Moskowitz & Associates, and past chairman of the Health Industry Distributors Association (HIDA)

The speakers will be available for private consulting sessions after the program or in Tel Aviv on Wednesday, 14 January and Thursday, 15 January. By reservation only.

See full program agenda and speaker bios.

Fees, Registration & Information

NIS 200 IEICI members
NIS 290 non-IEICI members
Fee includes VAT.

Download the registration form.
Download the meeting request form.

For additional information, contact Tina Ornstein (04.958.3323) at Trendlines International or Hagar Koren at the Israel Export & International Cooperation Institute (03.514.2896).


4 Keys to the U.S. Retail "Kingdom"
This article by Mark Dollinger, president of Trendlines America (and Karen Kozek), presents valuable insights into the U.S. retail marketplace, with a particular emphasis on consumer products. Read the article.


From the Consultant ...
It is always exciting to attend MEDICA, the world's largest exhibition for the medical device industry. While the worldwide recession had some effect on attendance, it didn't affect the enthusiasm of the participants or the exhibitors.

The Israeli presence was very impressive with some 45 companies exhibiting and two Israel pavilions brimming with activity. David Furst and his team at the Israel Export & International Cooperation Institute worked diligently to promote Israeli companies at the show.

MEDICA continues to be the premier venue for Israeli medical device companies that are market ready (or almost ready) and are exploring distribution opportunities or looking to develop a better understanding of industry trends. We hope to see you in Düsseldorf in November 2009!

Mark Dollinger, President
Trendlines America


Client News

Biocancell applies for FDA trial ... FDA clearance for DeepBreeze ...  close to Funding deal with foreign investors for Maayan Ventures ... 

Read all the client news.



Team News
CEO Tina Ornstein and Business Development Consultant Maura Rosenfeld  participated in the Circle of Life "live" business development workshop in Tel Aviv.

Senior Marketing Communiations Consultant Karen Kozek coached participants attending the WolfBlock Israel Venture Conference.

©2002–2008 Trendlines International Ltd. All rights reserved.
Phone: +972.4.958.3323 | postmaster@trendlines.com
Directions | Privacy Policy | Site Map
This site contains material copyrighted by third parties.
This site is best viewed in Internet Explorer version 5 or higher.